| Net Cash Provided by (Used in) Operating Activities |
$-73,968 |
USD |
18.7% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$-66,519,453 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$66,519,453 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
2,266,500 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$-73,968 |
USD |
18.7% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$272,630 |
USD |
10719% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
2,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
$150,274 |
USD |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |